RT @AlexDresslerMD: Near-resolution of persistent idiopathic facial pain with low-dose lumbar intrathecal ziconotide. #painmedicine #neurom…
RT @AlexDresslerMD: Near-resolution of persistent idiopathic facial pain with low-dose lumbar intrathecal ziconotide. #painmedicine #neurom…
RT @AlexDresslerMD: Near-resolution of persistent idiopathic facial pain with low-dose lumbar intrathecal ziconotide. #painmedicine #neurom…
Near-resolution of persistent idiopathic facial pain with low-dose lumbar intrathecal ziconotide. #painmedicine #neuromodulation @NANS_ION @NANSRFS @AmerAcadPainMed https://t.co/INQke6OwxT
Brandon Staub, et al, write first case report describing the use of a single-shot lumbar intrathecal trial of ziconotide and subsequent placement of lumbar (as opposed to thoracic) intrathecal ziconotide pump for persistent idiopathic facial pain. https://